https://doi.org/10.1038/ncomms11730
B
Bingfeng Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
2.7K
Citations
26
h-index
36
i10-index
Bingfeng Liu is an academic researcher from Harbin Institute of Technology. The author has contributed to research in topics: HIV Research and Treatment & Immune Cell Function and Interaction & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 26, co-authored 57 publications.
ORCID: 0000-0003-1278-727XPapers by this author
worksLong noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation
2016 · Nature Communications · 200 citations
A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region
2014 · Retrovirology · 99 citations
https://doi.org/10.1186/1742-4690-11-23
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
2023 · Advanced Science · 35 citations
https://doi.org/10.1002/advs.202301034
Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment
2023 · Molecular Therapy — Oncolytics · 30 citations
https://doi.org/10.1016/j.omto.2023.07.007
The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments
2024 · Molecular Cancer · 20 citations
https://doi.org/10.1186/s12943-024-01938-8
Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies
2020 · Cellular and Molecular Immunology · 19 citations
https://doi.org/10.1038/s41423-020-00528-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat